XOMA Royalty Corporation

Healthcare · Biotechnology

40.20$ +0.0% vs. previous close Closing price · As of: Jul 21, 2026

Statements

Balance Sheet

XOMA Royalty Corporation (XOMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 273 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XOMA
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	58	65	37	28	45	86	72	119	46	73	91	85	67	53	74	78	106	135	90	75	29	45	64	96	125	167	140	234	221	273
Current Assets	48	56	29	20	37	71	49	97	27	50	66	58	39	32	59	63	96	127	84	72	27	44	48	60	88	97	61	169	126	117
Cash	1.2	37	12	19	35	67	36	85	24	21	28	23	9.5	24	37	48	45	102	78	66	26	43	46	57	84	93	58	153	102	83
Cash & Short-Term Investments	1.2	37	28	19	35	68	37	85	24	44	46	39	11	24	37	48	85	122	78	66	26	43	46	57	84	94	58	153	105	83
Receivables	1.1	0.4	0.4	0.9	1.2	2.1	8.9	11	0.9	5.3	13	12	17	7.2	21	12	8.2	3.8	3.3	4.1	0.6	0.4	1.5	2.9	1.8	0.2	2.4	15	17	4.9
Inventory	–	–	–	–	–	1.3	1.3	–	–	1.0	5.4	7.1	11	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.0	0.0	0.0	–	–
Property, Plant & Equipment	–	–	–	–	8.4	15	23	21	19	19	22	26	27	20	15	13	8.1	6.5	5.1	2.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	15	–	26	45
Total Liabilities	23	34	37	45	54	72	83	71	71	93	130	84	99	35	51	63	84	139	87	77	76	39	45	52	39	25	16	146	139	169
Current Liabilities	8.7	8.8	11	10	10	19	19	30	24	17	23	24	27	19	36	21	24	30	36	23	33	7.4	5.7	8.9	12	13	6.8	19	24	35
Short-Term Debt	0.5	0.7	0.3	–	0.2	5.7	6.6	19	0.4	5.7	–	–	6.0	8.6	11	7.2	3.4	5.8	19	5.9	18	3.4	0.8	5.3	8.3	0.2	0.0	5.6	12	15
Accounts Payable	1.8	1.6	3.5	3.9	2.5	3.5	3.2	5.1	1.9	5.6	4.2	7.0	10.0	2.9	3.6	2.1	3.9	9.6	6.0	6.8	5.7	1.7	1.2	0.6	0.5	1.1	0.5	0.7	1.1	2.2
Long-Term Debt	–	–	–	–	40	52	64	40	41	72	98	51	63	13	14	34	38	35	16	43	25	15	22	27	13	–	–	119	107	96
Shareholders' Equity	35	31	0.2	-17	-8.6	14	-11	48	-25	-21	-38	0.3	-31	18	24	15	21	-4.0	3.1	-2.3	-47	5.8	19	44	86	142	124	89	82	104
Retained Earnings	-337	-355	-404	-450	-480	-508	-541	-600	-678	-676	-728	-740	-785	-785	-853	-886	-957	-1,081	-1,119	-1,140	-1,194	-1,179	-1,192	-1,194	-1,181	-1,165	-1,182	-1,223	-1,237	-1,221
Shares Outstanding	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.3	0.4	0.4	0.6	0.9	1.6	3.2	4.3	5.8	5.9	6.0	8.0	8.4	8.8	12	12	11	11	12	18

Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings